FRMD3 and breast cancer: In this study, we explored the downregulation of FRMD3 mRNA and its clinical relevance in breast cancer using the TCGA database and verified the lower levels of FRMD3 protein in both breast cancer cell lines and clinical tissue biopsy, as compared to normal controls.